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Abstract
Study background: 2,4-Dihydroxybenzophenone (DHBP) is an organic compound used for the synthesis of 
pharmaceutical agents. The objective of this study was to investigate the influence of biofield energy treatment on the 
physical, thermal and spectral properties of DHBP. The study was performed in two groups (control and treated). The 
control group remained as untreated, and the treated group received Mr. Trivedi’s biofield energy treatment. 
Methods: The control and treated DHBP samples were further characterized by X-ray diffraction (XRD), differential 
scanning calorimetry (DSC), thermogravimetric analysis (TGA), laser particle size analyser, surface area analyser, 
Fourier transform infrared (FT-IR) spectroscopy, and ultra violet-visible spectroscopy (UV-vis) analysis.
Results: The XRD study indicated a slight decrease in the volume of the unit cell and molecular weight of treated 
DHBP as compared to the control sample. However, XRD study revealed an increase in average crystallite size of the 
treated DHBP by 32.73% as compared to the control sample. The DSC characterization showed no significant change in 
the melting temperature of treated sample. The latent heat of fusion of the treated DHBP was substantially increased by 
11.67% as compared to the control. However, TGA analysis showed a decrease in the maximum thermal decomposition 
temperature (Tmax) of the treated DHBP (257.66
ºC) as compared to the control sample (260.93ºC). The particle size 
analysis showed a substantial increase in particle size (d50 and d99) of the treated DHBP by 41% and 15.8% as compared 
to the control sample. Additionally, the surface area analysis showed a decrease in surface area by 9.5% in the treated 
DHBP, which was supported by the particle size results. Nevertheless, FT-IR analysis showed a downward shift of 
methyl group stretch (2885→2835 cm-1) in the treated sample as compared to the control. The UV analysis showed a 
blue shift of absorption peak 323→318 nm in the treated sample (T1) as compared to the control. 
Conclusion: Altogether, the results showed significant changes in the physical, thermal and spectral properties of 
treated DHBP as compared to the control. 
Keywords: 2,4-Dihydroxybenzophenone; X-ray diffraction; Thermal 
analysis; Laser particle size analyser; Surface area analyser; Fourier 
transform infrared spectroscopy; Ultra violet-visible spectroscopy.
Abbreviations: XRD: X-Ray Diffraction; DSC: Differential 
Scanning Calorimetry; TGA: Thermo Gravimetric Analysis; FTIR: 
Fourier Transform Infrared Spectroscopy, UV-Vis: Ultra Violet-
Visible Spectroscopy Analysis; CAM: Complementary and Alternative 
Medicine 
Introduction
Benzophenone an aromatic ketone is an important class of organic 
compounds used in perfumes and photochemicals. Benzophenones are 
used as an intermediate for the synthesis of dyes, pesticides and drugs 
[1]. These compounds are widely used for the synthesis of various 
drugs having anxiolytic, hypnotic and antihistaminic activities [2]. 
2,4-dihydroxybenzophenone (DHBP) is used as UV-light absorber in 
resinous and polymer compositions such as polystyrene, acrylonitrile 
polymer and other copolymers [3]. Moreover, these UV light absorbers 
are also used in the preparation of sunscreen agents for cosmetic 
applications. DHBP has been used as promising sunscreen agent that 
reduces the skin damage by blocking the ultra violet light [2].  
The chemical and physical stability of the pharmaceutical 
compounds are most desired quality attributes that directly affect its 
safety, efficacy, and shelf life [4]. Hence, it is required to explore some 
new alternate approaches that could alter the physical and chemical 
properties of the compounds such as DHBP. Recently biofield energy 
treatment has been used as a plausible approach for physicochemical 
modification of metals [5,6], ceramic [7], organic products [8] 
and pharmaceutical drugs [9]. Therefore, after considering the 
pharmaceutical applications of DHBP authors planned to investigate 
the influence of biofield energy treatment on physical, spectral and 
thermal properties of DHBP.
The National Centre for Complementary and Alternative 
Medicine (NCCAM), a part of the National Institute of Health (NIH), 
recommends the use of Complementary and Alternative Medicine 
(CAM) therapies as an alternative in the healthcare sector, and about 
36% of Americans regularly uses some form of CAM [10]. CAM 
includes numerous energy-healing therapies; biofield therapy is one of 
the energy medicine used worldwide to improve the health. 
Fritz, has first proposed the law of mass-energy interconversion 
and after that Einstein derived the well-known equation E=mc2 for 
light and mass [11,12]. Though, conversion of mass into energy is fully 
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all atoms in a molecule multiplied by the Avogadro number (6.023 
×1023).  The percent change in molecular weight was calculated using 
the following equation:
Percent change in molecular weight = [(Mt-Mc)/Mc]×100
Where, Mc and Mt are molecular weight of control and treated 
powder sample respectively. 
Percentage change in average crystallite size was calculated using 
following formula:
Percent change in average crystallite size = [(Gt-Gc)/Gc] ×100
Where, Gc and Gt are the average crystallite size of control and 
treated powder samples respectively. 
Differential scanning calorimetry (DSC)
DSC was used to investigate the melting temperature and latent 
heat of fusion (∆H) of samples. The control and treated DHBP samples 
were analysed using a Pyris-6 Perkin Elmer DSC at a heating rate of 
10ºC/min under air atmosphere and the air was flushed at a flow rate of 
5 mL/min. Predetermined amount of sample was kept in an aluminum 
pan and closed with a lid. A blank aluminum pan was used as a 
reference. The percentage change in latent heat of fusion was calculated 
using following equations: 
[ ]Treated Control
Control
H H 
% change in Latent heat of fusion 100 
H 
∆ −∆
= ×
∆
Where, ΔH Control and ΔH Treated are the latent heat of fusion of 
control and treated samples, respectively. 
Thermogravimetric analysis-differential thermal analysis 
(TGA-DTA) 
The thermal stability of control and treated DHBP were analyzed 
by using Mettler Toledo simultaneous TGA and Differential thermal 
analyser (DTA). The samples were heated from room temperature to 
400ºC with a heating rate of 5ºC/min under air atmosphere.
Particle size analysis
The average particle size and particle size distribution were 
analyzed by using Sympetac Helos-BF Laser Particle Size Analyser with 
a detection range of 0.1 to 875 micrometer. Average particle size d50 and 
d99 (size exhibited by 99% of powder particles) were computed from 
laser diffraction data table. The percentage changes in d50 and d99 values 
were calculated by the following formula: 
Percentage change in d50 size = 100 × (d50 treated- d50 control)/ d50 
control
Percentage Change in d99 size = 100× (d99 treated- d99 control)/ d99 
control
Surface area analysis 
The surface area of control and treated DHBP were characterized 
by surface area analyser, SMART SORB 90 Brunauer-Emmett-Teller 
(BET) using ASTM D 5604 method that had a detection range of 
0.2-1000 m2/g. Percent change in surface area was calculated using 
following equation: 
[ ]Treated Control
Control
S S 
% change in surface area 100
S 
−
= ×
Where, S Control and S Treated are the surface area of control and treated 
samples respectively.
validated, but the inverse of this relation, i.e. energy into mass is not 
yet verified scientifically. Additionally, it was stated that energy exist in 
various forms such as kinetic, potential, electrical, magnetic, nuclear, 
etc. which have been generated from different sources. Similarly, 
neurons that are present in the human central nervous system have the 
ability to transmit the information in the form of electrical signals [13-
16]. Hence, biofield is defined as a bioenergetic field that permeates and 
surrounds living organisms. Recently Prakash et al. reported that this 
inherent biomagnetic field around the human body can be measured 
by few medical techniques such as Kirlian photography, polycontrast 
interference photography and resonance field imaging [17]. 
Therefore, it is envisaged that human beings have the ability to 
harness the energy from the environment/Universe and can transmit 
into any object (living or non-living) around the Globe. The object(s) 
will always receive the energy and responding in a useful manner 
that is called biofield energy. Mr. Trivedi’s unique biofield treatment 
is also known as The Trivedi Effect®. It is known to transform the 
characteristics of various living and non-living things. Moreover, the 
biofield treatment has caused significant affect in different fields such 
as agriculture [18-20] and microbiology [21-22].  
The present work is focused to study the impact of Mr. Trivedi’ 
biofield energy treatment on physical, thermal and spectral properties 
of DHBP and characterized by XRD, DSC, TGA, particle size, surface 
area, FT-IR and UV-visible spectroscopic analysis.  
Materials and Methods
2,4-Dihydroxybenzophenone (DHBP) was procured from S D Fine 
Chemicals Ltd, India. The sample was divided into two parts; one was 
kept as a control sample while the other was subjected to Mr. Trivedi’s 
unique biofield treatment and coded as treated sample. The treated 
group was in sealed pack and handed over to Mr. Trivedi for biofield 
energy treatment under standard laboratory conditions. Mr. Trivedi 
provided the energy treatment through his energy transmission 
process to the treated group without touching the sample. The control 
and treated samples were characterized by XRD, DSC, TGA, particle 
size, surface area, FT-IR, and UV-visible analysis.
Characterization
X-ray diffraction (XRD) study
The XRD analysis of control and treated DHBP was carried out on 
Phillips, Holland PW 1710 X-ray diffractometer system, which had a 
copper anode with nickel filter. The radiation of wavelength used by 
the XRD system was 1.54056 Å. The data obtained from this XRD were 
in the form of a chart of 2θ vs. intensity and a detailed table containing 
peak intensity counts, d value (Å), peak width (θ°), relative intensity 
(%) etc. The average crystallite size (G) was calculated by using formula: 
G = kλ/(bCosθ)
Here, λ is the wavelength of radiation used, b is full width half-
maximum (FWHM) of peaks and k is the equipment constant (=0.94). 
Percent change in unit cell volume = [(Vt-Vc)/Vc] ×100
The molecular weight of atom was calculated using following 
equation:
Molecular weight = number of protons x weight of a proton + 
number of neutrons x weight of a neutron + number of electrons x 
weight of an electron.
Molecular weight in g/Mol was calculated from the weights of 
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FT-IR spectroscopy
The FT-IR spectra were recorded on Shimadzu’s Fourier transform 
infrared spectrometer (Japan) with the frequency range of 4000-500 
cm-1. The analysis was accomplished to evaluate the effect of biofield 
treatment at an atomic level like dipole moment, force constant and 
bond strength in chemical structure [23]. The treated sample was 
divided into two parts T1 and T2 for FT-IR analysis.
UV-Vis spectroscopic analysis
UV spectra of the control and treated DHBP samples were recorded 
on Shimadzu UV-2400 PC series spectrophotometer with 1 cm quartz 
cell and a slit width of 2.0 nm. The analysis was carried out using 
wavelength in the range of 200-400 nm and methanol was used as a 
solvent. The UV spectra was analysed to determine the effect of biofield 
treatment on the energy gap of highest occupied molecular orbital and 
lowest unoccupied molecular orbital (HOMO–LUMO gap) [23]. The 
treated sample was divided in two parts T1 and T2 for the analysis.
Results and Discussion
X-ray diffraction
XRD was used to investigate the crystalline nature of the control 
and treated DHBP. Figure 1 shows the XRD diffractogram of the 
control and treated DHBP. XRD diffractogram of the control DHBP 
showed intense crystalline peaks at 2θ equal to 12.98º, 14.83 º, 15.24 
º, 18.13 º, 18.52 º, 25.64 º, 27.93 º, 34.85 º, 37.57 º and 44.34 º. However, 
the treated DHBP showed XRD peaks at 2θ equal to 12.97 º, 14.85 º, 
15.23 º, 18.13 º, 18.50 º, 25.63 º, 27.94 º, 34.75 º, 34.85 º, 37.56 º, and 44.34 º. 
The intensity of XRD peaks present at Brags angle 2θ equal to 18.13 º, 
18.50 º, 34.85 º, 37.56 º and 44.34 º were increased in the treated sample 
as compared to the control. This showed an increase in crystallinity of 
the treated DHBP with respect to the control sample. It is proposed 
that biofield energy treatment might increase the long-range order of 
the DHBP molecules that lead to the formation of the symmetrical 
crystalline pattern as compared to the untreated sample [24]. Based 
on XRD peaks, control and treated samples were indexed with the 
monoclinic crystal structure. 
The unit cell volume, crystallite size and change in molecular 
weight were computed from the XRD diffractogram, and results 
are presented in Table 1. The unit cell volume of control DHBP was 
1063.70 10-24 × cm3 and it was minimally decreased to 1063.20 10-24 × 
cm3 in the treated sample. The treated DHBP showed a decrease in unit 
cell volume by 0.05% as compared to the control sample. The molecular 
weight (number of proton and neutrons) in control DHBP was 214.95 
g/mol and it was minimally decreased up to 214.84 g/mol in the treated 
sample. The treated sample showed 0.048 % change in molecular 
weight with respect to control. It is hypothesized that biofield energy 
may be acted on the treated DHBP crystals at nuclear level and altered 
the number of proton and neutrons as compared to the control, which 
may lead to change in  its molecular weight [25].  
The crystallite size is known as a group of molecules or atoms 
having the same orientation in one plane. Moreover, the crystallite 
size is one of the crystallographic factors associated with the formation 
of dislocations and point defects in the crystalline structure, which 
directly influences the material properties [26]. The crystallite size of the 
control sample on the plane corresponding to most intense XRD peak 
(i.e. 2θ = 27.9) was 78.08 nm, and it was remained unchanged in treated 
DHBP sample (78.08 nm). Nevertheless, the average crystallite size was 
also calculated from the XRD diffractograms and data are presented 
in Table 1. The average crystallite size of control DHBP was 62.19 nm, 
and it was significantly increased to 82.55 nm, in the treated sample. 
The result showed an increase in average crystallite size by 32.73% in 
treated sample as compared to the control. Caruntu et al. reported that 
dielectric properties of barium powder could be varied by modulating 
the crystallite size through an annealing process [27]. Vucinic-Vasic 
et al. during their studies on zinc ferrite nanoparticles revealed that 
crystallite size increases with elevation in annealing temperature [28]. 
Additionally, recently it was showed that introduction of ultrasound 
to materials leads to substantial increase in crystallite size [29]. Hence, 
it is assumed that biofield treatment may provide waves similar like 
ultrasound or thermal energy to treated DHBP atoms that led to a 
decrease in dislocation densities and increase in crystallite size with 
respect to control. 
Thermal analysis 
DSC study: DSC was used to investigate the melting point and 
latent heat of fusion of control and treated DHBP. DSC thermogram 
of the control and treated DHBP are presented in Figure 2. DSC 
thermogram of the control DHBP showed a sharp melting endothermic 
peak at 146.39 ºC, and it indicated the crystalline nature of the control 
DHBP. However, the treated DHBP showed a minimal decrease in 
melting endothermic peak and it was observed at 146.21ºC. 
The latent heat of fusion of control and treated samples were 
obtained from respective thermograms and data are presented in 
Figure 1: XRD diffractogram of control and treated 2,4-dihydroxybenzophenone.
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Table 2. The control DHBP showed a latent heat of fusion of 109.99 
J/g; however it was increased to 122.83 J/g in the treated DHBP. The 
latent heat of fusion of DHBP was substantially increased by 11.67% as 
compared to control. It was suggested that a material consists of strong 
intermolecular forces that hold them tightly on their positions. The 
energy needed to overcome the intermolecular force is known as latent 
heat of fusion. This latent heat of fusion is stored as potential energy in 
the atoms during its phase transition from solid to liquid [30-31]. It is 
speculated that biofield treatment may alter the intermolecular force in 
the sample that leads to increasing in latent heat of fusion of the treated 
DHBP.  
TGA study: TGA was used to evaluate the thermal stability of 
the control and treated DHBP sample. Figure 3 shows the TGA 
thermograms of control and treated DHBP. TGA thermogram of 
control DHBP showed one-step thermal degradation pattern. The 
control sample started to degrade thermally at around 244ºC, and 
it was terminated at around 285 º C. The control sample lost 55.51% 
weight during this process. However, the treated DHBP sample started 
to decompose at around 240ºC and stopped at around 282ºC. During 
this thermal process, the treated sample lost 54.89% of its initial weight. 
DTA thermogram of the control and treated DHBP are depicted 
in Figure 3. The DTA of the control DHBP showed an endothermic 
transition at 144.17ºC, which could be associated with melting 
of the sample. Nevertheless, the treated DHBP showed the same 
endothermic peak at 143.74ºC. This showed the minimal decrease in 
melting temperature of the treated DHBP as compared to the control. 
It was previously reported that solid-solid phase transformation 
with large strain increases the driving force for melting and thus 
reduces the melting temperature [32]. It is postulated that the biofield 
energy treatment possibly produced a strain that reduces the melting 
temperature of the treated DHBP. The temperature at which maximum 
thermal decomposition (Tmax) occurred was recorded with derivative 
thermogravimetry (DTG) and data are presented in Table 2. The control 
DHBP showed Tmax at 260.93 ºC; however it was decreased to 257.66 ºC 
in treated sample. This indicated the decrease in thermal stability of 
treated DHBP as compared to the control sample. 
Particle size and surface area analysis
The average particle size (d50) and size exhibited by 99% particles 
(d99) were computed from the particle size distribution curve, and 
results are presented in Figure 4. The d50 of the control DHBP was 64.65 
µm and after biofield treatment it was increased substantially to 91.14 
µm in the treated DHBP. Whereas, the d99 of the control sample was 
303.39 µm, and it was increased to 351.40 µm in the treated DHBP. 
The result showed the substantial increase in d50 by 41% in the treated 
DHBP as compared to the control sample. However, the d99 of the 
treated DHBP was increased by 15.8 % as compared to the control 
sample. Vinila et al showed that particle size of a ceramic material 
increases with elevation in temperature [33]. Additionally, Iqbal et 
al suggested that due to annealing the particles collide and coalesce 
with one another to form a bigger particle [34]. Hence, it is assumed 
that biofield treatment may provide some thermal energy that caused 
aggregation of particles leading to increase in particle size. 
The surface area of control and treated DHBP was measured using 
BET method and data are presented in Figure 5. The surface area of 
control DHBP was 0.9487 m2/g and it was decreased to 0.8667 m2/g, 
in treated sample. The result indicated the decrease in surface area 
by 8.64% in treated DHBP as compared to the control sample. It was 
reported that particle size is inversely proportional to surface area. 
Thus, increase in particle size causes a decrease in surface area and vice 
versa [35]. This was also supported by the XRD data where average 
crystallite size of treated sample was increased that causes decrease in 
the surface area. 
FT-IR spectroscopy 
FT-IR spectra of control and treated DHBP are shown in Figure 
6. The FT-IR spectrum of control DHBP showed –OH stretching 
vibration peak at 3178 cm-1. However, in the treated DHBP (T1 and T2) 
the –OH stretching were observed at 3184 and 3180 cm-1, respectively. 
The aromatic =C-H stretch was assigned at 3064 cm-1 in the control 
and treated samples (T1 and T2). Likewise, the C-H methyl stretch was 
observed at 2885, 2875 and 2835 cm-1 in control and treated samples 
(T1 and T2), respectively. The aromatic C=C stretching of benzene 
moiety was appeared in the region of 1597-1627 cm-1 in the control 
and treated samples. The C-H asymmetrical bending peaks were 
Compound Characteristics Control Treated
Unit cell volume (10-24 cm3) 1063.70 1063.20
Molecular Weight (g/mol) 214.95 214.84
Crystallite size (G’ × 10-9) 62.19 82.55
Table 1: XRD data (unit cell volume, molecular weight and crystallite size) of 
control and treated 2,4-dihydroxybenzophenone.
Figure 2: DSC thermogram of control and treated 2,4-dihydroxybenzophenone.
Parameter Control Treated
Latent heat of fusion ΔH (J/g) 109.99 122.83
Melting temperature (ºC) 146.39 146.21
Tmax (ºC) 260.93 257.66
Weight loss (%) 55.51 54.89
Tmax: maximum thermal decomposition temperature
Table 2: Thermal analysis data of control and treated 2,4-dihydroxybenzophenone.
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Figure 3: TGA thermogram of control and treated 2,4-dihydroxybenzophenone.
appeared at 1446-1491 cm-1 in the control and T1 sample, whereas in 
the T2 sample these peaks were observed at 1446-1489 cm-1. The C-O 
stretching for ether linkage was appeared at 1166 cm-1 in all the control 
and the treated samples. The C-H out of plane deformation peaks were 
observed in the region of 742-850 cm-1 in the control sample. However, 
these peaks were observed in the region of 750-850 cm-1 in the treated 
samples (T1 and T2). Additionally, the C-C stretching was observed 
at 1280 cm-1 in the control and T1 sample; whereas it was appeared at 
1290 cm-1 in the T2 sample. 
Overall, the FT-IR spectra of treated sample showed the downward 
shift in methyl (C-H) stretch of the treated sample 2885→2835 cm-1 as 
compared to control sample. It was previously suggested that increase in 
the frequency of any bond causes a possible enhancement in force constant 
of the respective bond [23].  Hence, it is assumed that biofield energy 
treatment might alter the dipole moment or force constant of the methyl 
stretch bond in treated DHBP sample as compared to the control.
UV-visible spectroscopy 
UV-visible spectra of control and treated DHBP are shown in 
Figure 7. The UV spectrum of the control DHBP showed absorption 
peaks at 204, 242, 289, and 323 nm. The UV spectrum of treated DHBP 
(T1) showed absorption peaks at 203, 242, 290 and 318 nm. Whereas, 
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Figure 4: Particle size (d50 and d99) of control and treated 2,4-dihydroxybenzophenone.
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Figure 5: Surface area of control and treated 2,4-dihydroxybenzophenone.
Figure 6: FTIR spectra of control and treated (T1 and T2) 2,4-dihydroxybenzophenone.
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Figure 7: UV visible spectra of control and treated (T1 and T2) 2,4-dihydroxybenzophenone.
the UV spectrum of DHBP (T2) showed absorption peaks at 203, 242, 
289 and 322 nm. The result showed a blue shift of absorption peak 
at 323 nm in the control sample to 318 nm in DHBP sample (T1). It 
is speculated that the biofield energy treatment may cause changes 
in the energy gap of highest occupied molecular orbital and lowest 
unoccupied molecular orbital (HOMO–LUMO gap) of the treated 
DHBP with respect to the control [23,36].
Conclusions
In summary, the XRD study showed a decrease in the volume of 
the unit cell and molecular weight of treated DHBP as compared to 
the control. However, average crystallite size was increased by 32.73% 
in treated DHBP as compared to the control sample. It is assumed 
that biofield energy treatment might cause a reduction in dislocation 
density that lead to an increase in crystallite size in treated sample. The 
DSC analysis showed an increase in the latent heat of fusion of treated 
DHBP by 11.67% as compared to the control sample. TGA analysis 
indicated the decrease in thermal stability of the treated compound as 
compared to the control. A significant increase by 41% and 15.8% was 
observed in d50 and d99, respectively of the treated DHBP as compared 
to control sample. Additionally, the BET analysis showed a reduction 
in surface area (8.64%) of the treated DHBP that was due to increase in 
particle size of the sample. The UV spectral analysis showed alterations 
in absorption peak at 323→318 nm in treated sample as compared to 
the control. Thus, the biofield energy treatment has caused substantial 
changes in physical, thermal and spectral properties of DHBP. 
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